New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Two-pronged attack on DNA repair could kill drug-resistant cancers

Two-pronged attack on DNA repair could kill drug-resistant cancers

byInstitute of Cancer ResearchProtein structure of checkpoint kinase 1 (viaPyMOL). Credit: Emw viaWikimedia Commons,CC BY-SA 3.0Launching a two-pronged attack on cancer's a
World medicine December 11,2023
Two-pronged attack on DNA repair could kill drug-resistant cancers

Two-pronged attack on DNA repair could kill drug-resistant cancers

byInstitute of Cancer ResearchProtein structure of checkpoint kinase 1 (viaPyMOL). Credit: Emw viaWikimedia Commons,CC BY-SA 3.0Launching a two-pronged attack on cancer's a
World medicine December 11,2023
Targeted treatments for pancreatic cancer may help eligible patients live an extra year

Targeted treatments for pancreatic cancer may help eligible patients live an extra year

byLancetAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainResults from 46 patients given treatments that target specific molecular change
World medicine December 11,2023
Targeted treatments for pancreatic cancer may help eligible patients live an extra year

Targeted treatments for pancreatic cancer may help eligible patients live an extra year

byLancetAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainResults from 46 patients given treatments that target specific molecular change
World medicine December 11,2023
Scientists uncover a mechanism that could lead to new immunotherapies head and neck cancer

Scientists uncover a mechanism that could lead to new immunotherapies head and neck cancer

by Katie Pence,University of CincinnatiA healthy T cell versus a cancer T cell. Credit: Ameet ChimoteResearchers at UC have discovered a previously unknown mechanism that could explain the reaso
World medicine December 11,2023
Scientists uncover a mechanism that could lead to new immunotherapies head and neck cancer

Scientists uncover a mechanism that could lead to new immunotherapies head and neck cancer

by Katie Pence,University of CincinnatiA healthy T cell versus a cancer T cell. Credit: Ameet ChimoteResearchers at UC have discovered a previously unknown mechanism that could explain the reaso
World medicine December 11,2023
Cancer cells spread using a copper-binding protein

Cancer cells spread using a copper-binding protein

byChalmers University of TechnologyThe copper-transporting protein Atox1 (illustrated in white) delivers copper (blue) to an enzyme which facilitates breast cancer cells to migrate away from the
World medicine December 11,2023
Cancer cells spread using a copper-binding protein

Cancer cells spread using a copper-binding protein

byChalmers University of TechnologyThe copper-transporting protein Atox1 (illustrated in white) delivers copper (blue) to an enzyme which facilitates breast cancer cells to migrate away from the
World medicine December 11,2023
New study identifies valuable tool for treating pancreatic cancer patients

New study identifies valuable tool for treating pancreatic cancer patients

byCU Anschutz Medical CampusAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainPancreatic cancer is predicted to become the second leading
World medicine December 11,2023
New study identifies valuable tool for treating pancreatic cancer patients

New study identifies valuable tool for treating pancreatic cancer patients

byCU Anschutz Medical CampusAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainPancreatic cancer is predicted to become the second leading
World medicine December 11,2023
Engineered bone marrow cells slow growth of prostate and pancreatic cancer cells

Engineered bone marrow cells slow growth of prostate and pancreatic cancer cells

byJohns Hopkins University School of MedicineP50 IMC. Credit: Alan Friedman, M.D.In experiments with mice, researchers at the Johns Hopkins Kimmel Cancer Center say they have slowed the growth o
World medicine December 11,2023
Engineered bone marrow cells slow growth of prostate and pancreatic cancer cells

Engineered bone marrow cells slow growth of prostate and pancreatic cancer cells

byJohns Hopkins University School of MedicineP50 IMC. Credit: Alan Friedman, M.D.In experiments with mice, researchers at the Johns Hopkins Kimmel Cancer Center say they have slowed the growth o
World medicine December 11,2023
From scorpion to immunotherapy: Team repurposes nature's toxin for CAR T

From scorpion to immunotherapy: Team repurposes nature's toxin for CAR T

by City of HopeBlue indicates the cell nuclei (big: tumor cell; small: T cell). The aggregation of yellow color at the interface between the two cells is the formation of immune synapse, a key indicat
World medicine December 11,2023
From scorpion to immunotherapy: Team repurposes nature's toxin for CAR T

From scorpion to immunotherapy: Team repurposes nature's toxin for CAR T

by City of HopeBlue indicates the cell nuclei (big: tumor cell; small: T cell). The aggregation of yellow color at the interface between the two cells is the formation of immune synapse, a key indicat
World medicine December 11,2023
Old weapon, new target: Dasatinib against angioimmunoblastic T-cell lymphoma

Old weapon, new target: Dasatinib against angioimmunoblastic T-cell lymphoma

byUniversity of TsukubaCredit: CC0 Public DomainResearchers from the University of Tsukuba have shown by in vivo experimentation on a mouse model that angioimmunoblastic T-cell lymphoma is highl
World medicine December 11,2023
Old weapon, new target: Dasatinib against angioimmunoblastic T-cell lymphoma

Old weapon, new target: Dasatinib against angioimmunoblastic T-cell lymphoma

byUniversity of TsukubaCredit: CC0 Public DomainResearchers from the University of Tsukuba have shown by in vivo experimentation on a mouse model that angioimmunoblastic T-cell lymphoma is highl
World medicine December 11,2023
Scientists find many gene 'drivers' of cancer, but warn: Don't ignore 'passengers'

Scientists find many gene 'drivers' of cancer, but warn: Don't ignore 'passengers'

byYale UniversityCredit: CC0 Public DomainA massive analysis of the entire genomes of 2,658 people with 38 different types of cancer has identified mutations in 179 genes and gene regulators as
World medicine December 11,2023
Scientists find many gene 'drivers' of cancer, but warn: Don't ignore 'passengers'

Scientists find many gene 'drivers' of cancer, but warn: Don't ignore 'passengers'

byYale UniversityCredit: CC0 Public DomainA massive analysis of the entire genomes of 2,658 people with 38 different types of cancer has identified mutations in 179 genes and gene regulators as
World medicine December 11,2023
Blocking energy production in immune cells helps tumours escape treatment

Blocking energy production in immune cells helps tumours escape treatment

byeLifeSuzanne Judd, Ph.D., an epidemiologist at UAB, explains what will lead to herd immunity and why it is important to remain vigilant in reducing the spread of COVID-19. Credit: CC0 Public D
World medicine December 11,2023
Blocking energy production in immune cells helps tumours escape treatment

Blocking energy production in immune cells helps tumours escape treatment

byeLifeSuzanne Judd, Ph.D., an epidemiologist at UAB, explains what will lead to herd immunity and why it is important to remain vigilant in reducing the spread of COVID-19. Credit: CC0 Public D
World medicine December 11,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com